
Tired of getting dragged into office politics? Techie shares no-nonsense strategy to handle it
is like background noise in most workplaces—some choose to tune it out, others get pulled right into the chaos. But not everyone who stays out of the game ends up getting sidelined. Pune-based techie Rohit Yadav, a
product manager
by profession, has found a middle path: don't play the game, but don't be blind to it either.
In a recent Instagram post that struck a chord with thousands, Rohit shared how he's learned to survive—and even thrive—without picking sides, gossiping, or playing dirty. His strategy? Stay observant, stay sharp, and let your work do the talking.
Explore courses from Top Institutes in
Please select course:
Select a Course Category
Healthcare
Operations Management
Others
MCA
Project Management
Technology
Artificial Intelligence
PGDM
Leadership
CXO
MBA
Product Management
Management
others
healthcare
Data Science
Public Policy
Finance
Data Science
Design Thinking
Digital Marketing
Cybersecurity
Degree
Data Analytics
Skills you'll gain:
Financial Analysis in Healthcare
Financial Management & Investing
Strategic Management in Healthcare
Process Design & Analysis
Duration:
12 Weeks
Indian School of Business
Certificate Program in Healthcare Management
Starts on
Jun 13, 2024
Get Details
For starters, he listens more than he speaks in meetings, choosing silence over noise and calm over chaos. When workplace drama unfolds, he stays focused and composed, refusing to get emotionally tangled.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
Relive the Bollywood 2025 moments that went viral
medianet.app
Learn More
Undo
He also pays close attention to how decisions are made and who quietly influences them—because titles don't always equal power. Instead of offering loud opinions about colleagues, Rohit either gives respectful feedback in private or keeps his thoughts to himself. His golden rule? No unnecessary commentary, no unnecessary enemies.
To protect himself from finger-pointing later, he always sends a follow-up email after important discussions. It's not just good communication—it's smart self-preservation.
And when small things go wrong, Rohit doesn't react. Not every minor issue deserves your time or energy. 'Not everything needs a fight,' he writes.
His approach is simple yet powerful: you don't have to be part of the politics to protect yourself from it. Just be smart, stay quiet, and focus on your work. Sometimes, not playing the game is the best move of all.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Time of India
13 minutes ago
- Time of India
Truemeds closes $85 million funding led by Accel and Peak XV Partners
Academy Empower your mind, elevate your skills Telehealth platform Truemeds has secured $85 million in a funding round led by Accel and Peak XV Partners , its cofounder Akshat Nayyar told the total, $65 million was primary capital while $20 million was secondary transactions through which early backers are exiting, according to Nayyar, who said existing investors WestBridge Capital and Info Edge Ventures also participated in the company will use the funds to triple its national footprint by adding fulfillment centres, expand its team and set up a technology hub in Bengaluru, he said.'We have cracked the business model and the product market fit is in place too. Even at an order level economics, we are able to deliver a very positive result. So, now we are focusing on expanding our footprint in the country,' Nayyar April 2022, Truemeds had raised $22 million in a funding round led by Westbridge Capital and participation from existing investors. In 2021, the company had raised $5 million from investors including InfoEdge Ventures, Asha Impact and Indian Angel platform has raised $135 million to date and is valued at over $400 million.'India's healthcare market is undergoing rapid transformation, yet affordability continues to be a major barrier, especially in chronic care,' Abhinav Chaturvedi, Partner at Accel, said in a prepared statement. 'Truemeds is bridging this gap with a clinically guided, technology-led platform that delivers transparency and accessibility at scale.'Truemeds, founded by Nayyar and Kunal Wani in 2019, focuses on recommending value alternative brands to patients.'By leveraging technology to deliver a seamless customer experience, they are redefining how essential medicines reach those who need them the most,' Sakshi Chopra, managing director of Peak XV, said in a Mumbai-based company has 19 fulfillment centres and plans to take it to 50 in the next 12 months, according to Nayyar. Monthly orders processed by the platform have grown by more than 100% year-on-year to close to 600,000 each closed FY25 with about Rs 510 crore in net the e-pharmacy space, it competes with companies including Tata 1mg, PharmEasy, Netmeds and a growing demand for quick commerce, Truemeds' rivals have launched rapid delivery services. However, Truemeds target consumers are people with chronic ailments who plan their medicine purchase.'There is a need for urgent care when it comes to health, which is what quick commerce will be able to solve. However, we are focusing more on the planned care part,' said Nayyar. 'Our target market is that where there is a planned need for medicines, which is more value-driven than speed-driven.'Even quick commerce platforms such as Swiggy's Instamart, Flipkart Minutes and Zepto have also started delivering medicines in minutes.


Economic Times
13 minutes ago
- Economic Times
Truemeds closes $85 million funding led by Accel and Peak XV Partners
Company Images (L-R) Akshat Nayyar and Dr Kunal Wani, cofounders, Turemeds Telehealth platform Truemeds has secured $85 million in a funding round led by Accel and Peak XV Partners, its cofounder Akshat Nayyar told the total, $65 million was primary capital while $20 million was secondary transactions through which early backers are exiting, according to Nayyar, who said existing investors WestBridge Capital and Info Edge Ventures also participated in the financing. The company will use the funds to triple its national footprint by adding fulfillment centres, expand its team and set up a technology hub in Bengaluru, he said. 'We have cracked the business model and the product market fit is in place too. Even at an order level economics, we are able to deliver a very positive result. So, now we are focusing on expanding our footprint in the country,' Nayyar April 2022, Truemeds had raised $22 million in a funding round led by Westbridge Capital and participation from existing investors. In 2021, the company had raised $5 million from investors including InfoEdge Ventures, Asha Impact and Indian Angel platform has raised $135 million to date and is valued at over $400 million.'India's healthcare market is undergoing rapid transformation, yet affordability continues to be a major barrier, especially in chronic care,' Abhinav Chaturvedi, Partner at Accel, said in a prepared statement. 'Truemeds is bridging this gap with a clinically guided, technology-led platform that delivers transparency and accessibility at scale.'Truemeds, founded by Nayyar and Kunal Wani in 2019, focuses on recommending value alternative brands to patients.'By leveraging technology to deliver a seamless customer experience, they are redefining how essential medicines reach those who need them the most,' Sakshi Chopra, managing director of Peak XV, said in a Mumbai-based company has 19 fulfillment centres and plans to take it to 50 in the next 12 months, according to Nayyar. Monthly orders processed by the platform have grown by more than 100% year-on-year to close to 600,000 each closed FY25 with about Rs 510 crore in net the e-pharmacy space, it competes with companies including Tata 1mg, PharmEasy, Netmeds and a growing demand for quick commerce, Truemeds' rivals have launched rapid delivery services. However, Truemeds target consumers are people with chronic ailments who plan their medicine purchase.'There is a need for urgent care when it comes to health, which is what quick commerce will be able to solve. However, we are focusing more on the planned care part,' said Nayyar. 'Our target market is that where there is a planned need for medicines, which is more value-driven than speed-driven.'Even quick commerce platforms such as Swiggy's Instamart, Flipkart Minutes and Zepto have also started delivering medicines in minutes. Elevate your knowledge and leadership skills at a cost cheaper than your daily tea. Can Coforge's ambition to lead the IT Industry become a reality? How Mukesh Ambani's risky bet has now become Reliance's superpower Berlin to Bharuch: The Borosil journey after the China hit in Europe As RBI retains GDP forecast, 4 factors that will test the strength of Indian economy In a flat market, are REITs the sweet spot between growth and safety? These large- and mid-cap stocks may give more than 25% return in 1 year, according to analysts Buy, Sell or Hold: Avendus trims target on Titan Company; Motila Oswal maintains buy on Jindal Stainless Stock picks of the week: 5 stocks with consistent score improvement and return potential of more than 23% in 1 year


Time of India
28 minutes ago
- Time of India
Illegal organ trade: Govt cancels transplant licences of two hospitals
Chennai: State govt has directed the directorate of medical and rural services to cancel transplant licences of Dhanalakshmi Srinivasan Medical College and Hospital in Perambalur and Cethar Hospital in Trichy for their involvement in the illegal sale of organs. The hospitals that submitted "forged documents" for govt approval will be banned from conducting these surgeries, and govt will lodge a police complaint against two brokers involved in the organ trade and begin streamlining live-unrelated organ transplant surgeries, a release from the health department said. The decisions were made based on the recommendation of the govt-appointed committee to investigate irregularities in organ transplants, following complaints from Namakkal. The committee, led by Tamil Nadu Health Systems Project Project Director Dr S Vineeth, in its report submitted to the govt, confirmed these hospitals carried out illegal organ transplantations by submitting forged documents to the appropriate authority, procuring organs through brokers from donors who are related to the patient, and "misusing legal technicalities"—gross violations of the Transplant of Human Organs Act, 1994. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Play this game for 1 minute and see why everyone is addicted. Undo You Can Also Check: Chennai AQI | Weather in Chennai | Bank Holidays in Chennai | Public Holidays in Chennai The five-member committee, which began its enquiry on June 22, examined the medical case sheets, files, and applications filed by the hospitals to the appropriate authority to conduct organ transplant surgeries. As per organ transplant rules, hospitals must seek permission from authority if donors are not blood relatives — parents, siblings, or spouses. Investigations showed some documents submitted by the hospitals were forged by the transplant coordinators working at the hospital, the release said. The transplant surgeries were permitted based on these documents, and transplants were completed, it said. On Sunday, the govt said police complaints will be filed against two brokers—Anandan and Stanley Mohan—who were involved in the sale of organs, along with details of bank transactions, phone records, and other details collected by the inquiry committee. After finding the records of the district authorisation committee were "carelessly prepared," the investigating team has recommended standard operating procedures to streamline the work of district-level accrediting committees. The govt said it will constitute new state-level committees, reconstitute the four district-level committees and issue detailed SoPs. Stay updated with the latest local news from your city on Times of India (TOI). Check upcoming bank holidays , public holidays , and current gold rates and silver prices in your area.